Literature DB >> 9850091

Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.

L F Barr1, S E Campbell, B S Bochner, C V Dang.   

Abstract

Small cell lung cancer (SCLC) is a highly invasive and metastatic tumor, and the decreased expression of alpha3beta1 integrin may contribute to its virulence. Alpha3beta1 is a critical integrin for pulmonary development and epithelial integrity, and its reduced expression has been linked to the increased malignancy and invasion of other cancers. The amplification of the c-myc oncogene is seen frequently in relapsed SCLC tumors and is associated with a worsened prognosis. In the present study using a model of SCLC tumor progression, overexpression of c-myc in a classic SCLC cell line, NCI H209, enhanced in vitro features of tumorigenesis, altered the relationships between cell and environment, and markedly down-regulated the expression of the alpha3 integrin subunit at both the transcript and protein levels. This inverse relationship between the expression of the alpha3 integrin subunit and c-myc is mimicked by other c-myc-overexpressing SCLC cell lines. Restoring alpha3 expression in the myc-transfected 209 cells reversed the effects of c-myc: alpha3 transfection increased cell:cell adhesion and reduced soft agar cloning without affecting the in vitro doubling time. The diminished soft agar cloning produced by alpha3 transfection was reversed by an antibody that specifically engages alpha3beta1 integrins, P1B5. These results suggest first, that alpha3beta1 integrin mediates homotypic adhesion of SCLC cells, and second, that unengaged alpha3beta1 integrin suppresses the growth of disaggregated SCLC cells. Thus, the down-regulation of the alpha3 integrin subunit may contribute to the enhanced tumorigenicity of c-myc-overexpressing SCLCs by allowing the growth of tumor cells that have reduced contact with ligand-expressing substratum or cells, a condition that occurs during the growth of the primary tumor, tumor invasion, and metastasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850091

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  Physiological and pathological roles of alpha3beta1 integrin.

Authors:  Tsutomu Tsuji
Journal:  J Membr Biol       Date:  2004-08-01       Impact factor: 1.843

Review 2.  Disease proteomics toward bedside reality.

Authors:  Toshihide Nishimura; Atsushi Ogiwara; Kiyonaga Fujii; Takao Kawakami; Takeshi Kawamura; Hisae Anyouji; Harubumi Kato
Journal:  J Gastroenterol       Date:  2005-03       Impact factor: 7.527

3.  Aberrant cell adhesion molecule expression in human bronchopulmonary sequestration and congenital cystic adenomatoid malformation.

Authors:  Maryann V Volpe; Eunice Chung; Jason P Ulm; Brian F Gilchrist; Steven Ralston; Karen T Wang; Heber C Nielsen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-01       Impact factor: 5.464

4.  Hypoxia-induced changes to integrin α 3 glycosylation facilitate invasion in epidermoid carcinoma cell line A431.

Authors:  Yan Ren; Piliang Hao; S K Alex Law; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2014-07-30       Impact factor: 5.911

5.  Inhibition of LN-308 glioma cell proliferation and migration by retinoic acid amide through activation of Akt pathway.

Authors:  Jun Zhu; Xiang-Dong Lu; Feng Si; Chun-Yu Song; Qing-Hai Meng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

6.  Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer.

Authors:  Xiaoke Liu; Yong Xu; Zongguo Pang; Fuchun Guo; Qing Qin; Tao Yin; Yaxiong Sang; Chengjun Feng; Xiaoyu Li; Li Jiang; Pei Shu; Yongsheng Wang
Journal:  J Hematol Oncol       Date:  2015-06-11       Impact factor: 17.388

7.  Extracellular Vesicle Integrins Distinguish Unique Cancers.

Authors:  Stephanie N Hurwitz; David G Meckes
Journal:  Proteomes       Date:  2019-04-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.